+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Microbial Fermentation Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

  • ID: 4851383
  • Report
  • February 2018
  • Region: Global
  • 220 pages
  • Transparency Market Research
1 of 2

Global Microbial Fermentation Technology Market: Overview

This report on the microbial fermentation technology market analyzes the current and future scenario of the global market. Growth of the global microbial fermentation technology market is driven by wide use of fermentation technology derived chemicals in various industries around the globe due to their natural structure, low cost and better output. Moreover, rising research and developmental activities in different fields of fermentation technology, technological advancement, growing awareness about products and new product launch are some of the factors will drive the market in near future.

The microbial fermentation technology market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, end-user, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the microbial fermentation technology market.

Global Microbial Fermentation Technology Market: Key Segments

The product type segment is fragmented into medical products, industrial products, alcohol beverages, and food & feed products. The medical product segment is further sub-segmented into antibiotics, probiotics, monoclonal antibodies, recombinant proteins, and other biosimilars while industrial products segmented is sub-segmented into Acetone, Ethanol & Butanol and enzymes & amino acids products. Beer, spirits, wine and other alcoholic beverages are considered under alcohol beverages product segment. The product type market segments have been analyzed based on available marketed products, revenue generated by products, and market share analysis of key players operating in the market. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on end-user, the global microbial fermentation technology market has been segmented into following categories: bio-pharmaceutical industries, food and feed industry, Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs), academic research institutes, and others. The others segment of global microbial fermentation technology market considers alcohol breweries, wineries, and chemical industries. The market size and forecast in terms of US$ Bn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Microbial Fermentation Technology Market: Regional Outlook

Geographically, the global microbial fermentation technology market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global microbial fermentation technology market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in the women’s health market are – Biocon, Danone Ltd., Lonza, United Breweries Ltd., Amyris, Novozymes, TerraVia Holdings, Inc., BioVectra, DSM, and F. Hoffmann La-Roche Ltd.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Microbial Fermentation Technology Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Microbial Fermentation Technology Market Analysis and Forecasts, 2015 - 2025
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
4.6. Market Outlook
4.7.Regulatory Scenario by Region/globally
4.8.Value Chain Analysis
4.9. Key Trends, By Segment and Region

5. Global Microbial Fermentation Technology Market Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings/Developments
5.3. Market Value Forecast By Product, 2015-2025
5.3.1. Medical
5.3.1.1. Antibiotics
5.3.1.2. Probiotics
5.3.1.3. Monoclonal Antibodies
5.3.1.4. Recombinant Proteins
5.3.1.5. Other Biosimilars
5.3.2. Industrial
5.3.2.1. Acetone, Ethanol & Butanol
5.3.2.2. Enzymes & Amino Acids
5.3.3. Alcohol Beverages
5.3.4. Food and Feed Products
5.4. Market Attractiveness By Product

6. Global Microbial Fermentation Technology Market Analysis and Forecasts, By End-user
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By End-user, 2015-2025
6.3.1. Bio-Pharmaceutical Industries
6.3.2. Food and Feed Industry
6.3.3. CROs and CMOs
6.3.4. Academic Research Institutes
6.3.5. Others
6.4. Market Attractiveness By End-user

7. Global Microbial Fermentation Technology Market Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Market Value Forecast By Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness By Country/Region

8. North America Microbial Fermentation Technology Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast By Product, 2015-2025
8.2.1. Medical
8.2.1.1. Antibiotics
8.2.1.2. Probiotics
8.2.1.3. Monoclonal Antibodies
8.2.1.4. Recombinant Proteins
8.2.1.5. Other Biosimilars
8.2.2. Industrial
8.2.2.1. Acetone, Ethanol & Butanol
8.2.2.2. Enzymes & Amino Acids
8.2.3. Alcohol Beverages
8.2.4. Food and Feed Products
8.3. Market Value Forecast By End-user, 2015-2025
8.3.1. Bio-Pharmaceutical Industries
8.3.2. Food and Feed Industry
8.3.3. CROs and CMOs
8.3.4. Academic Research Institutes
8.3.5. Others
8.4. Market Value Forecast By Country, 2015-2025
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product
8.5.2. By End-user
8.5.3. By Country

9. Europe Microbial Fermentation Technology Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Product, 2015-2025
9.2.1. Medical
9.2.1.1. Antibiotics
9.2.1.2. Probiotics
9.2.1.3. Monoclonal Antibodies
9.2.1.4. Recombinant Proteins
9.2.1.5. Other Biosimilars
9.2.2. Industrial
9.2.2.1. Acetone, Ethanol & Butanol
9.2.2.2. Enzymes & Amino Acids
9.2.3. Alcohol Beverages
9.2.4. Food and Feed Products
9.3. Market Value Forecast By End-user, 2015-2025
9.3.1. Bio-Pharmaceutical Industries
9.3.2. Food and Feed Industry
9.3.3. CROs and CMOs
9.3.4. Academic Research Institutes
9.3.5. Others
9.4. Market Value Forecast By Country, 2015-2025
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country

10. Asia Pacific Microbial Fermentation Technology Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.2.Market Value Forecast By Product, 2015-2025
10.2.1. Medical
10.2.1.1. Antibiotics
10.2.1.2. Probiotics
10.2.1.3. Monoclonal Antibodies
10.2.1.4. Recombinant Proteins
10.2.1.5. Other Biosimilars
10.2.2. Industrial
10.2.2.1. Acetone, Ethanol & Butanol
10.2.2.2. Enzymes & Amino Acids
10.2.3. Alcohol Beverages
10.2.4. Food and Feed Products
10.3.Market Value Forecast By End-user, 2015-2025
10.3.1. Bio-Pharmaceutical Industries
10.3.2. Food and Feed Industry
10.3.3. CROs and CMOs
10.3.4. Academic Research Institutes
10.3.5. Others
10.4.Market Value Forecast By Country, 2015-2025
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. Rest of Asia Pacific
10.5.Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country

11. Latin America Microbial Fermentation Technology Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast By Product, 2015-2025
11.2.1. Medical
11.2.1.1. Antibiotics
11.2.1.2. Probiotics
11.2.1.3. Monoclonal Antibodies
11.2.1.4. Recombinant Proteins
11.2.1.5. Other Biosimilars
11.2.2. Industrial
11.2.2.1. Acetone, Ethanol & Butanol
11.2.2.2. Enzymes & Amino Acids
11.2.3. Alcohol Beverages
11.2.4. Food and Feed Products
11.3.Market Value Forecast By End-user, 2015-2025
11.3.1. Bio-Pharmaceutical Industries
11.3.2. Food and Feed Industry
11.3.3. CROs and CMOs
11.3.4. Academic Research Institutes
11.3.5. Others
11.4.Market Value Forecast By Country, 2015-2025
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5.Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country

12. Middle East & Africa Microbial Fermentation Technology Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast By Product, 2015-2025
12.2.1. Medical
12.2.1.1. Antibiotics
12.2.1.2. Probiotics
12.2.1.3. Monoclonal Antibodies
12.2.1.4. Recombinant Proteins
12.2.1.5. Other Biosimilars
12.2.2. Industrial
12.2.2.1. Acetone, Ethanol & Butanol
12.2.2.2. Enzymes & Amino Acids
12.2.3. Alcohol Beverages
12.2.4. Food and Feed Products
12.3.Market Value Forecast By End-user, 2015-2025
12.3.1. Bio-Pharmaceutical Industries
12.3.2. Food and Feed Industry
12.3.3. CROs and CMOs
12.3.4. Academic Research Institutes
12.3.5. Others
12.4.Market Value Forecast By Country, 2015-2025
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of Middle East & Africa
12.5.Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country

13. Competition Landscape
13.1.Market Player - Competition Matrix (By Tier and Size of companies)
13.2.Market Share Analysis By Company (2016)
13.3.Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
13.3.1. Biocon
13.3.1.1. Overview (HQ, Employee Strength, Business Segments)
13.3.1.2. Financials
13.3.1.3. Recent Development
13.3.1.4. Strategy
13.3.2. Danone Ltd.
13.3.2.1. Overview (HQ, Employee Strength, Business Segments)
13.3.2.2. Financials
13.3.2.3. Recent Development
13.3.2.4. Strategy
13.3.3. Lonza
13.3.3.1. Overview (HQ, Employee Strength, Business Segments)
13.3.3.2. Financials
13.3.3.3. Recent Development
13.3.3.4. Strategy
13.3.4. United Breweries Ltd.
13.3.4.1. Overview (HQ, Employee Strength, Business Segments)
13.3.4.2. Financials
13.3.4.3. Recent Development
13.3.4.4. Strategy
13.3.5. Amyris
13.3.5.1. Overview (HQ, Employee Strength, Business Segments)
13.3.5.2. Financials
13.3.5.3. Recent Development
13.3.5.4. Strategy
13.3.6. Novozymes
13.3.6.1. Overview (HQ, Employee Strength, Business Segments)
13.3.6.2. Financials
13.3.6.3. Recent Development
13.3.6.4. Strategy
13.3.7. TerraVia Holdings, Inc.
13.3.7.1. Overview (HQ, Employee Strength, Business Segments)
13.3.7.2. Financials
13.3.7.3. Recent Development
13.3.7.4. Strategy
13.3.8. BioVectra
13.3.8.1. Overview (HQ, Employee Strength, Business Segments)
13.3.8.2. Financials
13.3.8.3. Recent Development
13.3.8.4. Strategy
13.3.9. DSM
13.3.9.1. Overview (HQ, Employee Strength, Business Segments)
13.3.9.2. Financials
13.3.9.3. Recent Development
13.3.9.4. Strategy
13.3.10. F. Hoffmann La-Roche Ltd.
13.3.10.1. Overview (HQ, Employee Strength, Business Segments)
13.3.10.2. Financials
13.3.10.3. Recent Development
13.3.10.4. Strategy
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll